Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
36.78
+0.55 (1.52%)
At close: Aug 13, 2025, 4:00 PM
36.78
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Smith & Nephew Employees
Smith & Nephew had 18,060 employees as of December 31, 2024. The number of employees decreased by 1,021 or -5.35% compared to the previous year.
Employees
18,060
Change (1Y)
-1,021
Growth (1Y)
-5.35%
Revenue / Employee
$329,125
Profits / Employee
$27,187
Market Cap
16.04B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18,060 | -1,021 | -5.35% |
Dec 31, 2023 | 19,081 | -13 | -0.07% |
Dec 31, 2022 | 19,094 | 118 | 0.62% |
Dec 31, 2021 | 18,976 | 395 | 2.13% |
Dec 31, 2020 | 18,581 | 551 | 3.06% |
Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
Dec 31, 2018 | 16,681 | 348 | 2.13% |
Dec 31, 2017 | 16,333 | 749 | 4.81% |
Dec 31, 2016 | 15,584 | 898 | 6.11% |
Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
Dec 31, 2013 | 11,036 | 559 | 5.34% |
Dec 31, 2012 | 10,477 | -266 | -2.48% |
Dec 31, 2011 | 10,743 | 571 | 5.61% |
Dec 31, 2010 | 10,172 | 408 | 4.18% |
Dec 31, 2009 | 9,764 | 7 | 0.07% |
Dec 31, 2008 | 9,757 | 567 | 6.17% |
Dec 31, 2007 | 9,190 | 360 | 4.08% |
Dec 31, 2006 | 8,830 | 212 | 2.46% |
Dec 31, 2005 | 8,618 | 752 | 9.56% |
Dec 31, 2004 | 7,866 | 415 | 5.57% |
Feb 16, 2003 | 7,451 | -55 | -0.73% |
Dec 31, 2002 | 7,506 | -420 | -5.30% |
Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
Dec 31, 2000 | 10,435 | -778 | -6.94% |
Dec 31, 1999 | 11,213 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SNN News
- 6 days ago - Smith & Nephew: Doing Better And Still Offers Value - Seeking Alpha
- 8 days ago - Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Top 2 Health Care Stocks You May Want To Dump In Q3 - Benzinga
- 5 weeks ago - Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option - GlobeNewsWire
- 7 weeks ago - Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures - GlobeNewsWire
- 7 weeks ago - Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer - GlobeNewsWire
- 2 months ago - Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK - GlobeNewsWire
- 2 months ago - New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility - GlobeNewsWire